Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$113M Buy
2,653,974
+108,542
+4% +$4.85M 6.25% 6
2026
Q1
$123M Buy
2,545,432
+633,782
+33% +$29.6M 6.67% 7
2025
Q4
$92.6M Buy
1,911,650
+254,111
+15% +$12.6M 5.34% 8
2025
Q3
$78.2M Buy
1,657,539
+109,335
+7% +$5.28M 5.6% 7
2025
Q2
$74.8M Buy
1,548,204
+782,838
+102% +$40M 6.32% 6
2025
Q1
$42.4M Buy
765,366
+38,981
+5% +$2.11M 4.35% 9
2024
Q4
$35M Buy
+726,385
New +$36.9M 3.55% 10

Other funds holding SNY

Regal Partners's SNY Position: Q2 2026 in Review

Regal Partners increased its Sanofi (SNY) stake by 4.3% in Q2 2026, buying an estimated $4.85M and bringing the position to 2,653,974 shares worth $113M. The position accounts for 6.25% of the portfolio, ranked #6.

Regal Partners first reported a position in SNY in Q4 2024 and has held it in 7 quarters since. The position peaked at $123M in Q1 2026. 714 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Regal Partners held 2,653,974 shares of Sanofi worth $113M as of Q2 2026.
  • Regal Partners bought 108,542 Sanofi shares in Q2 2026, an estimated $4.85M.
  • Sanofi made up 6.25% of Regal Partners's portfolio in Q2 2026, its #6 holding.
  • Regal Partners first reported a position in Sanofi in Q4 2024 and has held it in 7 quarters since.
  • Regal Partners's Sanofi position peaked at $123M in Q1 2026.
  • 714 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Regal Partners's 13F filing for Q2 2026, filed 14 Aug 2026.